Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 241,148 | 260,941 | 260,710 | 287,133 | 340,522 |
| Marketable Securities | 27,091 | 41,242 | 50,378 | 59,005 | 20,385 |
| Receivables | 15,874 | 12,400 | 9,343 | 14,233 | 12,099 |
| Inventories | 1,606 | 6,262 | 5,710 | 3,591 | 2,897 |
| Other current assets | 29,643 | 24,873 | 21,786 | 13,969 | 15,617 |
| TOTAL | $315,362 | $345,718 | $347,927 | $377,931 | $391,520 |
| Non-Current Assets | |||||
| PPE Net | 71,673 | 64,071 | 52,653 | 36,811 | 23,712 |
| Intangibles | 1,584 | 1,074 | 1,071 | 1,094 | 1,108 |
| Other Non-Current Assets | 80,852 | 74,094 | 71,045 | 55,298 | 51,129 |
| TOTAL | $154,109 | $139,239 | $124,769 | $93,203 | $75,949 |
| Total Assets | $469,471 | $484,957 | $472,696 | $471,135 | $467,469 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 24,609 | 35,003 | 32,674 | 26,873 | 29,264 |
| Other current liabilities | 20,258 | 16,840 | 16,118 | 20,250 | 12,240 |
| TOTAL | $52,015 | $56,613 | $53,052 | $49,008 | $62,604 |
| Non-Current Liabilities | |||||
| Long Term Debt | 28,836 | 31,473 | 6,640 | 48,699 | N/A |
| Deferred Revenues | 452 | 440 | 483 | 543 | 20,033 |
| Other Non-Current Liabilities | 85,809 | 73,965 | 71,533 | 6,321 | 53,365 |
| TOTAL | $108,610 | $102,133 | $74,584 | $51,540 | $49,395 |
| Total Liabilities | $160,625 | $158,747 | $127,637 | $100,548 | $111,999 |
| Shareholders' Equity | |||||
| Common Shares | 2,785 | 2,768 | 2,768 | 2,767 | 2,767 |
| Retained earnings | -587,035 | -550,191 | -520,754 | -488,509 | -508,481 |
| Other shareholders' equity | 20,962 | 22,285 | 13,723 | 9,491 | 17,706 |
| TOTAL | $308,846 | $326,210 | $345,059 | $370,588 | $355,470 |
| Total Liabilities And Equity | $469,471 | $484,957 | $472,696 | $471,136 | $467,469 |